Stay informed with the latest news, educational content, and insights from NovaTechs
Latest developments from NovaTechs
NovaTechs proudly announces the launch of NovaSeal™, our revolutionary liquid embolic agent designed to transform cancer treatment through innovative gel-based technology.
Read Full ArticleNovaTechs announces a new collaboration with a prestigious university to advance research in bio-based embolic materials.
Read MoreNovaTechs receives significant public funding to support the progression toward GLP studies and regulatory submissions.
Read More